IP Verse

Artificial Nucleic Acid Molecules For Improved Protein Expression

Patent No. EP3708668 (titled "Artificial Nucleic Acid Molecules For Improved Protein Expression") was filed by Curevac on Dec 11, 2015. The application was issued on Jul 27, 2022.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (4)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
BIONTECHApr 27, 2023HOPFNER
COOLEY UKApr 27, 2023CARPMAELS & RANSFORD
PFIZERApr 27, 2023EDER
SANOFIApr 27, 2023CARPMAELS & RANSFORD

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3708668

CUREVAC
Application Number
EP20157801A
Filing Date
Dec 11, 2015
Status
Granted And Under Opposition
Jun 24, 2022
Publication Date
Jul 27, 2022
External Links
Slate, Register , Google Patents